Diabetes Clinical Trials in New York

Showing 41-60 of 582 trials

Texts for Diabetes Control Among Homeless Persons

NCT05616026

This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods to assess the impact of a SMS text strategy in diabetes control among persons who experience homelessness.

Diabetes Mellitus

George Washington University100 participantsStarted Feb 2023

Washington D.C., District of Columbia, United States • New York, New York, United States

RECRUITINGPhase 3< 1 mile

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

NCT05099770

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 days to +28 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.

Type 2 Diabetes MellitusChronic Kidney Diseases

Prokidney685 participantsStarted Jan 2022

Tucson, Arizona, United States • Beverly Hills, California, United States • Glendora, California, United States +83 more locations

Texts for Diabetes Control Among Homeless Persons

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Diabetes Trials in Other Cities

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

Cleaner Air for Lower Cardiometabolic Risk

BRInging the Diabetes Prevention Program to GEriatric Populations

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes

Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Other Conditions in New York